SPECTRUM HEALTH HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

First Posted Date: 2014-05-28

Last Posted Date: 2024-07-26

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 18

Registration Number: NCT02148913

Locations: 🇺🇸
Spectrum Health, Grand Rapids, Michigan, United States

TXA Study in Major Oncologic Surgery

Not Applicable

Completed

Conditions: Tranexamic Acid
Major Surgery
Cancer

Interventions: Drug: Tranexamic Acid
Other: Placebo

First Posted Date: 2013-11-08

Last Posted Date: 2023-08-07

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 76

Registration Number: NCT01980355

Locations: 🇺🇸
Spectrum Health Hospitals, Grand Rapids, Michigan, United States

Long Term Effects of Treating Submassive Pulmonary Embolism With Ultra-sound Accelerated Thrombolysis

Completed

Conditions: Submassive Pulmonary Embolism

Interventions: Other: submassive PA treatment with Ekosonic endo device

First Posted Date: 2013-07-15

Last Posted Date: 2023-07-18

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 25

Registration Number: NCT01899339

Locations: 🇺🇸
Spectrum Health Hospitals, Grand Rapids, Michigan, United States

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Phase 1

Completed

Conditions: Hematological Malignancy

Interventions: Drug: Cohort 1-Bortezomib (Velcade ®)
Drug: Cohort 2-Bortezomib (Velcade ®)
Drug: Cohort 3-Bortezomib (Velcade ®)

First Posted Date: 2013-05-22

Last Posted Date: 2023-06-02

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 28

Registration Number: NCT01860170

Locations: 🇺🇸
Spectrum Health, Grand Rapids, Michigan, United States

Intracoronary Imaging With NIRS-IVUS to Characterize Arterial Plaques

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2012-09-27

Last Posted Date: 2025-01-08

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 500

Registration Number: NCT01694368

Locations: 🇺🇸
Spectrum Health; Frederik Meijer Heart &Vascular Institute, Grand Rapids, Michigan, United States

Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases

Phase 1

Completed

Conditions: Inflammatory Bowel Disease (IBD)

Interventions: Drug: Gut Microbial Transplantation

First Posted Date: 2012-03-22

Last Posted Date: 2023-06-02

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 20

Registration Number: NCT01560819

Locations: 🇺🇸
Helen DeVos Children's Hospital of Spectrum Health Hospitals, Grand Rapids, Michigan, United States

Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Placement

Completed

Conditions: Cognitive Function in Carotid Stenting

First Posted Date: 2009-06-12

Last Posted Date: 2023-07-13

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 19

Registration Number: NCT00919165

Locations: 🇺🇸
Spectrum Health, Grand Rapids, Michigan, United States

The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children

Phase 4

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: insulin glulisine
Drug: insulin aspart

First Posted Date: 2009-06-04

Last Posted Date: 2023-09-18

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 16

Registration Number: NCT00913497

Locations: 🇺🇸
Helen DeVos Childrens Hospital, Grand Rapids, Michigan, United States

Medical Treatment of "High-Risk" Neurofibromas

Phase 2

Completed

Conditions: Neurofibromatosis 1

Interventions: Drug: Peg-Interferon alpha-2b
Drug: Celecoxib (Celebrex)
Drug: Temozolomide (temodar)
Drug: Vincristine Sulfate (Oncovin)

First Posted Date: 2009-02-18

Last Posted Date: 2023-08-30

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 9

Registration Number: NCT00846430

Locations: 🇺🇸
Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States

Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders

Completed

Conditions: Myeloproliferative Disorder
MDS
AML

First Posted Date: 2008-05-30

Last Posted Date: 2023-07-27

Lead Sponsor: Spectrum Health Hospitals

Target Recruit Count: 60

Registration Number: NCT00687414

Locations: 🇺🇸
St Mary's Health Care, Grand Rapids, Michigan, United States
🇺🇸
Van Andel Research Institute, Grand Rapids, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy